EUVIMEDEUVIMED entdecken
Crossref

Xinglou Chengqi Decoction Protects against Cerebral Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via SLC7A11/GPX4 Signaling

Hua Liu, Qiyu Yue, Wenyue Zhang, Qi Ding, Junjie Yang, Mu Lin, Jia Sun iD

Advanced Biology · 2024

DOI: 10.1002/adbi.202400180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, 2024. Verfasst von Hua Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Yixing Traditional Chinese Medicine Hospital, Yixing, Jiangsu, 214200, China. Hauptthemen laut MEDLINE: Ferroptosis, Reperfusion Injury, Drugs, Chinese Herbal, Phospholipid Hydroperoxide Glutathione Peroxidase. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Social Development Project of Yixing Science and Technology Bureau, Yixing Health Commission Project, Scientific Research Project of Wuxi Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xinglou Chengqi decoction (XLCQD) is a Chinese formula that offers benefits in ischemic stroke. However, the underlying mechanism of the effects of XLCQD‐mediated anti‐ischemic stroke effects remains obscure. This study investigates the ferroptosis mechanism of XLCQD against cerebral ischemia/reperfusion (I/R) injury using rat models of middle cerebral artery occlusion/reperfusion (MCAO/R). Ferroptosis differs from traditional cell death pathways and is linked to oxidative stress‐induced lipid peroxidation and glutathione (GSH) depletion, which is essential to the development of ischemic stroke. In this study, it is shown that XLCQD improves brain infarction, neurological dysfunction, and histopathological changes caused by MCAO/R exposure, and improving I/R‐induced oxidative damage through inhibition of ferroptosis via (Solute Carrier Family 7 Member 11) SLC7A11/ (glutathione peroxidase 4) GPX4 pathway. Interestingly, it is found that XLCQD‐mediated protection in I/R is reversed by the silence of SLC7A11. XLCQD intervention significantly promotes GSH content and suppresses Reactive Oxygen Species(ROS), iron accumulation, as well as Malondialdehyde (MDA) generation, are markedly abrogated when SLC7A11 is knockdown by SLC7A11‐shRNA transfection, indicating that SLC7A11 is the main target of XLCQD to further trigger intracellular events. In conclusion, XLCQD attenuates in vivo cerebral I/R injury by reducing ferroptosis via the SLC7A11/GPX4 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisReperfusion InjuryDrugs, Chinese HerbalPhospholipid Hydroperoxide Glutathione PeroxidaseSignal TransductionAmino Acid Transport System y+Rats, Sprague-DawleyAnimalsRatsMaleBrain IschemiaInfarction, Middle Cerebral ArteryOxidative StressNeuroprotective Agents

Stichwörter der Autor:innen

SLC7A11/GPX4 pathwayXinglou Chengqi decoctionferroptosisischemia/reperfusion injuryischemic stroke

Substanzen

Drugs, Chinese HerbalPhospholipid Hydroperoxide Glutathione PeroxidaseAmino Acid Transport System y+glutathione peroxidase 4, ratNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Neurology, Yixing Traditional Chinese Medicine Hospital, Yixing, Jiangsu, 214200, China.
  • Division of Nephrology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China.
  • School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Department of Rehabilitation, Yixing Traditional Chinese Medicine Hospital, Yixing, Jiangsu, 214200, China.
  • Yixing Traditional Chinese Medicine Hospital, Yixing, Jiangsu, 214200, China.

ORCID-Profile: Jia Sun

Förderung

  • Social Development Project of Yixing Science and Technology Bureau
  • Yixing Health Commission Project
  • Scientific Research Project of Wuxi Administration of Traditional Chinese Medicine

Zitieren

APA

Liu, H., Yue, Q., Zhang, W., Ding, Q., Yang, J., Lin, M., & Sun, J. (2024). Xinglou Chengqi Decoction Protects against Cerebral Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via SLC7A11/GPX4 Signaling. Advanced Biology. https://doi.org/10.1002/adbi.202400180

Vancouver

Liu H, Yue Q, Zhang W, Ding Q, Yang J, Lin M, et al. Xinglou Chengqi Decoction Protects against Cerebral Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via SLC7A11/GPX4 Signaling. Advanced Biology. 2024. doi:10.1002/adbi.202400180

BibTeX
@article{Liu2024,
  author = {Liu, Hua and Yue, Qiyu and Zhang, Wenyue and Ding, Qi and Yang, Junjie and Lin, Mu and Sun, Jia},
  title = {Xinglou Chengqi Decoction Protects against Cerebral Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via SLC7A11/GPX4 Signaling},
  journal = {Advanced Biology},
  year = {2024},
  doi = {10.1002/adbi.202400180}
}
Kostenlos starten →